NIH PAR · NIDA · X01

PAR-27-051: NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsNext due date: Apr 15, 2027Expires Apr 18, 2029

The National Institutes of Health seek to advance their mission by providing the scientific community with the opportunity to request access to biospecimens from the Adolescent Brain Cognitive DevelopmentSM (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population Assessment of Tobacco and Health (PATH) Study to conduct research consistent with the respective study objectives that will maximize the scientific utility of these limited samples. Applications should expand the knowledge gained from these studies and advance our understanding of the multiple genetic and environmental factors, such as exposure to substances, that affect health and disease over the…

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-27-051
Type
PAR
Activity code
X01
Primary institute
NIDA · National Institute on Drug Abuse
Clinical trials
Not Allowed
Posted
Sep 1, 2026
Opens
Sep 1, 2026
Expires
Apr 18, 2029

PAR-27-051 due dates

5 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-27-051
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
October 01, 2026Not ApplicableNot ApplicableDecember 2026January 2027April 2027
April 15, 2027Not ApplicableNot ApplicableJuly 2027August 2027December 2027
September 15, 2027Not ApplicableNot ApplicableDecember 2027January 2028April 2028
April 17, 2028Not ApplicableNot ApplicableJuly 2028August 2028December 2028
September 15, 2028Not ApplicableNot ApplicableDecember 2028January 2029April 2029
April 17, 2029Not ApplicableNot ApplicableJuly 2029August 2029December 2029

Funded projects

NIH RePORTER lists no awards under PAR-27-051 in FY2022–FY2026. Awards usually appear a few months after the first review cycle.

Participating institutes

6 NIH institutes and offices take applications under PAR-27-051. Contact the program officer at the institute that fits your research before applying.

  • NIDA · National Institute on Drug Abuse
  • NIAAA · National Institute on Alcohol Abuse and Alcoholism
  • NIDCR · National Institute of Dental and Craniofacial Research
  • NIMH · National Institute of Mental Health
  • NINDS · National Institute of Neurological Disorders and Stroke
  • NCI · National Cancer Institute

Related notices

NIH lists no related notices for PAR-27-051 yet.

Award terms

Application types allowed
New The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
Not Applicable; funds are not awarded via the X01 mechanism.
Project period
The scope of the proposed project should determine the project period. The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The total number of projects granted access to biospecimens is dependent on the number of meritorious applications and the availability of biospecimens.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-23-229.

Other open NOFOs for X01

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO